Viewing Study NCT03786692

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 3:45 PM

Ignite Modification Date: 2025-12-24 @ 3:45 PM

Study NCT ID: NCT03786692

Status: RECRUITING

Last Update Posted: 2025-04-16

First Post: 2018-12-21

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Sponsor: Fox Chase Cancer Center

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module